Incredible !!
Congratulations to the entire CAR T team 🎉
Break from #SIOP2023ambassador for all the messages flowing through!
🙏🙏
Met @purwarrahul2 in 30/5/15 1st 🇮🇳 CAR T 4/6/21 & approved 12/10/23
What a journey!
Happy beyond words
Grateful to so many 🙏🙏
@TataMemorial @ACTREC_TMC @hkJain_kmc @NiraliShahMD @AlbeenaDr @VidyaVedham
Be selective in subjecting patients to Secondary Cytoreduction !
Incomplete surgery is detrimental. ijgc.bmj.com/content/early/2…
Indeed a special moment and very well deserved, @DrGauravNarula !
Heartiest congratulations🎉
A special moment!
Felicitated by legendary Dr Advani under whom I, like many, started Oncology journey, revered teachers Drs Sudeep Gupta & Reena Nair, legends in the audience
Honored to have had the opportunity to walk in your footsteps🙏🙏
Thanks kind words @bagalbp
Congratulations @RimaPathak1 and @RajivSarin5 !!
Quite excited that our work on the Largest #RealWorldData of RNI in #breastcancer using #UHFRT got selected for an ORAL presentation at #ASTRO2023. Lots of hard work by all our @TMC_BreastDMG especially @RajivSarin5, Tabassum W, @drrevathyk @khandavalliashu who made it possible!
Indeed it is a proud moment ! More power to you @ManjuSengar7
So proud of the first woman head of medical oncology ever @ManjuSengar7 .. so proud of you manju , expecting great things .. !! @TataMemorial @ACTREC_TMC .. 👏dr badwe ! @Shrikhande_SV @cspramesh we need a female medical director now in collegium :) @seemagulia1 @VanitaNoronha
Congratulations Vijay and team!
Phase III Randomized Trial for Use of Docetaxel in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation. @VanitaNoronha @Amolpatel_dr @Nandinimenon18 @DrEzraCohen @JCO_ASCO @HHKhar @TataMemorial @DrHaddadRobert ascopubs.org/doi/abs/10.1200…
The long time debate on the use of platinum in TNBC is finally settled ! Congratulations @ACTREC_TMC, @TataMemorial, entire breast DMG for this landmark trial. Platinum improves survival in premenopausal TNBC.
Updated IPD meta-analysis (including ATHENA-MONO data) on efficacy of maintenance PARP inhibitors in newly diagnosed advanced epithelial ovarian cancers,did not show substantial benefit of PARP inhibitors in HRD negative tumors @ACTREC_TMC @BanerjeeSusana @SuyogCancer @ESMO_Open
Seema Gulia retweeted
Watch this space … this year the breast cancer DMG launches the breast awareness campaign…Hamara wala pink. Dedicated to our patients, our women of substance. @nitaSnair @RimaPathak1 @JyotiBajpai01 @DrVaniParmar @Shalakajoshi15 @RajivSarin5
Choosing wisely is the way forward! @ACTREC-TMC @ TataMemorial @BanerjeeSusana @SuyogCancer
@seemagulia1 @TataMemorial publish the only IPD metaanalysis PARP-inhibitors first-line ovarian cancer! Highly impactful results, clear benefit BRCA-mut or HRD-pos pts, but NOT in BRCA-wt/HRD-neg pts! @jamecancerdoc @AnaOaknin @myESMO @ASCOPost @sujithonco esmoopen.com/article/S2059-7…
First line maintenance PARPi in ovarian cancer improves PFS ✅ in BRCA mutant and HRD positive patients and NOT in HRD negatives ❌.
Choosing wisely is the way forward !esmoopen.com/article/S2059-7… @cspramesh @ACTREC_TMC @ICMRDELHI
Seema Gulia retweeted
I laughed till I had tears in my eyes and the lady sitting next to me the bus surely thought I had gone bonkers 🤣
This will never get old.
The response that we all want to write but never do.
#AcademicTwitter #AcademicChatter @AcademicChatter #acwri #ecrchat
Seema Gulia retweeted
Many congratulations to @VedangMurthy & colleagues! Practice defining study!
ascopubs.org/doi/full/10.120…
Happy to share that the full paper will be out shortly in #JCO @ASCO_pubs. Many issues will be clear! @ACTREC_TMC
Congratulations Dr Gupta !!
We congratulate Dr Sudeep Gupta, Director @ACTREC_TMC , on being conferred the Urmil B K Kapoor Oration 2020, by @aiims_nd ! The Oration was delivered today and can be accessed at youtu.be/8Wg0Cz191sQ
@TataMemorial @AnuragAgrawalMD
Seema Gulia retweeted
In India, 1 in 28 women will develop breast cancer during her lifetime. This #BreastCancerAwarenessMonth Dr Sudeep Gupta, Director @ACTREC_TMC tells us how we can reduce the risk of #breastcancer. @TataMemorial
Seema Gulia retweeted
Concerning cardiac effects of #COVID ! Almost 60% patients, many mild disease, had heart inflammation on MRI after recovery! Even if very small fraction have clinical problems, will be large no., given millions infected! Need for vigilance! @JAMACardio
jamanetwork.com/journals/jam…
Seema Gulia retweeted
Dr Sudhir Nair & colleagues from @TataMemorial @ACTREC_TMC provide compelling evidence of effectiveness & accuracy of symptom-based telephonic follow-up in cancer patients in @JAMAOto ! Hugely important at all times but especially during #COVID
jamanetwork.com/journals/jam…
A Landmark study from @TataMemorial #Meta-analysis suggesting that less than one year of #Trastuzumab is not inferior to a year long therapy! jamanetwork.com/journals/jam… @JAMANetworkOpen @ACTREC_TMC @ASCO @CancerGridIndia @DAEIndia @ASCOPost @IJMPOofficial @MoHFW_INDIA @myESMO
Seema Gulia retweeted
From the Times of India: epaper.timesgroup.com/Olive/…
Great work @Shrikhande_SV @TataMemorial Surgical team 👏🏼👏🏼👏🏼